| Mr James Michael Basso, AUD | |
|
1618 Cooper Foster Park Rd, Lorain, OH 44053 | |
| (440) 282-4300 | |
| (440) 960-5562 |
| Full Name | Mr James Michael Basso |
|---|---|
| Gender | Male |
| Speciality | Audiologist |
| Location | 1618 Cooper Foster Park Rd, Lorain, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316919525 | NPI | - | NPPES |
| 04730 | Other | OH | NATIONAL EAR CARE PLAN |
| 0085287 | Medicaid | OH | |
| 000000363720 | Other | OH | ANTHEM |
| 341018435029 | Other | OH | CARESOURCE GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | A01207 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr James Michael Basso, AUD 409 Wilmington Dr, Broadview Heights, OH 44147 Ph: (440) 526-4707 | Mr James Michael Basso, AUD 1618 Cooper Foster Park Rd, Lorain, OH 44053 Ph: (440) 282-4300 |
News Archive
The Interactive Autism Network, a project of the Kennedy Krieger Institute supported by the Simons Foundation, was approved today for a three-year $1.6 million funding award by the Patient-Centered Outcomes Research Institute to be part of PCORnet, the National Patient-Centered Clinical Research Network.
The integration of data from two or more domains is required for addressing many fundamental scientific questions and understanding how to mitigate challenges impacting humanity and our planet, according to a new workshop report from the American Institute of Biological Sciences.
Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.
Attaching an antimicrobial drug, which is activated by light, to a peptide that binds to bacteria and stops them making toxins, produced a "magic bullet" that was highly effective at killing the superbug, methicillin-resistant Staphylococcus aureus (MRSA).
A gene therapy called NLX-P101 dramatically reduces movement impairment in Parkinson's patients, according to results of a Phase 2 study published today in the journal Lancet Neurology. The approach introduces a gene into the brain to normalize chemical signaling.
› Verified 4 days ago
The Audiology Center Of Lorain Co. Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6100 S Broadway Suite 102, Lorain, OH 44053 Phone: 440-246-4327 Fax: 440-246-4327 | |
Jack T. Roberts, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1680 Cooper Foster Park Rd W, Suite A, Lorain, OH 44053 Phone: 440-989-1133 Fax: 440-989-1137 | |
Center For Hearing Care Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1618 Cooper Foster Park Rd W, Lorain, OH 44053 Phone: 440-282-4300 Fax: 440-960-5562 | |
Lillian R. Mitchell, MACCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6100 S Broadway, Suite 102, Lorain, OH 44053 Phone: 440-246-4327 Fax: 440-246-4327 | |
Dr. Roberts & Associates, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1680 Cooper Foster Park Rd W, Suite A, Lorain, OH 44053 Phone: 440-989-1133 Fax: 440-989-1137 | |
David J. Weldele, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1618 Cooper Foster Park Rd W, Lorain, OH 44053 Phone: 440-282-4300 Fax: 440-960-5562 |